Solid Biosciences
World Rank (Aug-2026)
9,317
Market Cap (Aug-2026)
0.986 Billion USD
World Rank (Jan-05-2024)
20,729
Market Cap (Jan-05-2024)
0.115 Billion USD
World Rank (Jul-30-2023)
22,447
Market Cap (Jul-30-2023)
0.086 Billion USD
World Rank (Dec-25-2022)
21,130
Market Cap (Dec-25-2022)
0.110 Billion USD
World Rank (Jan-07-2022)
19,806
Market Cap (Jan-07-2022)
0.17 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-88 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Company Profile
Solid Biosciences is a Life Science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). The company estimated annual revenue is currently 12.4 million USD per year. The headquarters is in USA.
Company Website